Skip to main content

Table 1 Baseline characteristics and biochemical assessments

From: Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes

Variable

Control group (n = 83)

CAD group (n = 241)

P value

Men (%)

38(45.8)

165(68.5)

<0.0001

Age (yrs)

62 ± 10

66 ± 10

0.001

Cigarette smoking (%)

11(13.3)

68(28.2)

0.007

Hypertension (%)

52(62.7)

175(72.6)

NS

Blood pressure

   Systolic (mmHg)

138 ± 21

137 ± 20

NS

   Diastolic (mmHg)

81 ± 10

79 ± 11

NS

   Hyperlipidemia (%)

47(56.6)

137(56.8)

NS

Cholesterol

   Total cholesterol (mmol/L)

4.77 ± 1.27

4.70 ± 1.15

NS

   HDL-cholesterol (mmol/L)

1.19 ± 0.30

1.13 ± 0.41

NS

   LDL-cholesterol (mmol/L)

2.80 ± 0.89

2.73 ± 0.90

NS

Triglycerides(mmol/L)

2.23 ± 1.79

2.01 ± 1.19

NS

Lipoprotein-a (g/L)

0.19 ± 0.11

0.25 ± 0.19

0.025

Apo-A (g/L)

1.29 ± 0.19

1.24 ± 0.22

NS

Apo-B (g/L)

0.94 ± 0.26

0.94 ± 0.25

NS

Glucose (mmol/L)

7.03 ± 1.88

7.28 ± 2.72

NS

Blood urea nitrogen (mmol/L)

5.49 ± 1.60

6.05 ± 2.29

0.043

Creatinine (μmol/L)

74.67 ± 16.31

92.59 ± 29.22

<0.0001

Uric acid (μmol/L)

307.9 ± 76.03

314.19 ± 83.07

NS

Glycated albumin (%)

19.37 ± 4.29

21.21 ± 5.24

0.001

Hs-CRP (mg/L)

7.37 ± 8.71

25.77 ± 30.35

<0.0001